All articles by

• 

  Transforming CML patient monitoring with ICON’s innovative RNA-based NGS assay

  Managing chronic myeloid leukemia (CML) can be challenging, especially when it comes to accurately tracking how well patients respond to…

• 

  Cancer therapies for young adults: The need for tailored treatment and diversity

  Cancer, once primarily perceived as a disease of the elderly, is now becoming a major concern for young adults. The…

• 

  Diabesity: Overlapping pathophysiology informs multi-indication treatment

  The striking overlap between type 2 diabetes and obesity reflects the convergence in the underlying pathophysiology of these conditions –…

• 

  Podcast #5: Doing Digital Deals in Life Sciences | Deal Structure, Terms, and Series Conclusions

  Welcome to the fifth and final episode in our podcast series “Digital Deals in Life Sciences – What Makes Them…

• 

  Podcast #4: Doing Digital Deals in Life Sciences | Due Diligence

  Welcome to the fourth of five episodes in our podcast series “Digital Deals in Life Sciences – What Makes Them…